Efficacy and safety of co administered once weekly cagrilintide 24 mg with once weekly semaglutide 24 mg in type 2 diabetes: a multicentre, randomised, double blind, active controlled, phase 2 trial The Lancet Development of a rapid screen for the endodermal differentiation potential of human pluripotent stem cell lines Scientific Reports Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors Nature Communications Hepatocyte Growth Factor MET Activator Rescues Working Memory Deficits after Repeated Mild Traumatic Brain Injury Katelyn A. Martino, Arush Nakhre, Renee M. Demarest, David M. Devilbiss, 2025 Long acting amylin related peptides as therapies for obesity and type 2 diabetes ScienceDirect CagriSema (Cagrilintide + Semaglutide) and Retatrutide are highly effective for weight loss, but differ in mechanisms. CagriSema combines amylin and GLP 1 effects, enhancing appetite suppression and